Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
BioInvent International | BIX0 | Nov 22, 2024 | 3.90 | +1.30 |
BioLife Solutions, Inc. | BJX1 | Nov 22, 2024 | 24.00 | +2.56 |
BioLineRx Ltd. - American Depositary Shares | YP2A | Nov 22, 2024 | 0.23 | -28.48 |
BioMarin Pharmaceutical Inc. | BM8 | Nov 22, 2024 | 60.40 | +2.20 |
BioMark Diagnostics Inc | 20B | Nov 22, 2024 | 0.10 | -21.20 |
Biomaxima SA | 944 | Nov 22, 2024 | 2.70 | 0.00 |
Biome Grow Inc | 6OTA | Nov 22, 2024 | 0.00 | 0.00 |
Biomed-Lubin Wytwornia Surowic I Szczepionek S.A. | 6NQ | Nov 22, 2024 | 0.85 | -0.70 |
Biomerieux | EYWN | Nov 22, 2024 | 96.25 | -1.13 |
Biomind Labs Inc | 3XI | Nov 22, 2024 | 0.19 | -49.74 |
Bionomics ADR | B1N0 | Nov 22, 2024 | 0.17 | -1.19 |
BioNTech SE - American Depositary Shares | 22UA | Nov 22, 2024 | 107.60 | +4.47 |
BIONXT SOLUTIONS INC. | BXT | Nov 22, 2024 | 0.15 | -1.94 |
BioPharma Credit Plc | B3P | Nov 22, 2024 | 0.81 | +1.25 |
Biophytis | 6XB | Nov 22, 2024 | 0.00 | 0.00 |
BIOPHYTIS NAM. EO -,80 | 6XB3 | Nov 22, 2024 | 0.28 | -0.07 |
BioPorto | 2P4 | Nov 22, 2024 | 0.21 | -0.24 |
BioRestorative Therapies Inc | 9OF | Nov 22, 2024 | 1.26 | -1.56 |
Bioretec Oy | 0TN | Nov 22, 2024 | 1.84 | +2.51 |
Biosergen AB | 8N1 | Nov 22, 2024 | 0.05 | -1.22 |
Biosynex | 0DL | Nov 22, 2024 | 2.85 | +2.15 |
Biotage | PQX1 | Nov 22, 2024 | 13.00 | +4.33 |
Biotalys | 86C | Nov 22, 2024 | 2.87 | -0.35 |
Biotest AG | BIO3 | Nov 22, 2024 | 27.20 | 0.00 |
Biotest AG | BIO | Nov 22, 2024 | 41.20 | +0.49 |
Bioton S.A. | 7U5 | Nov 22, 2024 | 0.70 | 0.00 |
Bioventix Plc | 51B | Nov 22, 2024 | 44.20 | +0.91 |
Biovica International B | 9II | Nov 22, 2024 | 0.13 | 0.00 |
BioXcel Therapeutics, Inc. | BX2 | Nov 22, 2024 | 0.46 | -13.47 |
BIOXXMED AG INH O.N. KONV | T5O0 | Nov 22, 2024 | 2.44 | +0.41 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.